SHAREHOLDER ALERT: Weiss Law Investigates Applied Genetic Technologies Corporation

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Applied Genetic Technologies Corporation ("Applied Genetic" or the "Company") (NASDAQ: AGTC), in connection with the proposed acquisition of the Company via tender offer.  Under the tender offer, the Company's shareholders will receive $0.34 in cash for each share of Applied Genetic common stock owned, plus one non-tradeable contingent value right ("CVR").  The transaction is valued at approximately $23.5 million.